[HTML][HTML] Triple-negative breast cancer: Multimodality appearance
IE Chen, S Lee-Felker - Current Radiology Reports, 2023 - Springer
Abstract Purpose of Review Triple-negative breast cancer (TNBC) represents about 15–20%
of all breast cancers and often presents as an aggressive cancer with poor prognosis …
of all breast cancers and often presents as an aggressive cancer with poor prognosis …
Current status of cancer genomics and imaging phenotypes: what radiologists need to know
E Mendes Serrão, M Klug, BM Moloney… - Radiology: Imaging …, 2023 - pubs.rsna.org
Ongoing discoveries in cancer genomics and epigenomics have revolutionized clinical
oncology and precision health care. This knowledge provides unprecedented insights into …
oncology and precision health care. This knowledge provides unprecedented insights into …
Imaging challenges in diagnosing triple-negative breast cancer
JG Schopp, DS Polat, F Arjmandi, JC Hayes, RW Ahn… - Radiographics, 2023 - pubs.rsna.org
Triple-negative breast cancer (TNBC) refers to a heterogeneous group of carcinomas that
have more aggressive biologic features, faster growth, and a propensity for early distant …
have more aggressive biologic features, faster growth, and a propensity for early distant …
Triple-negative breast cancer: histopathologic features, genomics, and treatment
BE Adrada, TW Moseley, MM Kapoor, ME Scoggins… - Radiographics, 2023 - pubs.rsna.org
Triple-negative breast cancer (TNBC) is a heterogeneous and aggressive group of tumors
that are defined by the absence of estrogen and progesterone receptors and lack of ERBB2 …
that are defined by the absence of estrogen and progesterone receptors and lack of ERBB2 …
[HTML][HTML] Tumor infiltrating lymphocytes and radiological picture of the tumor
K Frankowska, M Zarobkiewicz, I Dąbrowska… - Medical Oncology, 2023 - Springer
Tumor microenvironment (TME) is a complex entity that includes besides the tumor cells
also a whole range of immune cells. Among various populations of immune cells infiltrating …
also a whole range of immune cells. Among various populations of immune cells infiltrating …
[HTML][HTML] A nomogram model combining ultrasound-based radiomics features and clinicopathological factors to identify germline BRCA1/2 mutation in invasive breast …
R Guo, Y Yu, Y Huang, M Lin, Y Liao, Y Hu, Q Li… - Heliyon, 2024 - cell.com
Objective BRCA1/2 status is a key to personalized therapy for invasive breast cancer
patients. This study aimed to explore the association between ultrasound radiomics features …
patients. This study aimed to explore the association between ultrasound radiomics features …
[PDF][PDF] 钼靶和超声检查在乳腺癌临床诊断的准确性的比较分析
吴爱强， 游仁芳， 喻瑾， 王晓姗， 卢灿强 - 现代生物医学进展, 2022 - biomed.cnjournals.com
摘要目的: 比较与分析钼靶和超声检查在乳腺癌临床诊断的准确性. 方法: 2018 年8 月到2021
年1 月选择在本院进行诊治的乳腺肿瘤患者110 例作为研究对象, 所有患者都给予钼靶和超声 …
年1 月选择在本院进行诊治的乳腺肿瘤患者110 例作为研究对象, 所有患者都给予钼靶和超声 …
[HTML][HTML] 三阴性乳腺癌的常规超声及超声影像组学研究进展
邱琳， 冷晓玲 - Advances in Clinical Medicine, 2023 - hanspub.org
乳腺癌是威胁世界各地女性生命和健康的肿瘤之一, 发病率及病死率占据癌症之首, 其中TNBC
具有进展快, 预后差, 复发率高等特点, 因此早期干预十分重要. 乳腺癌分子分型的诊断主要依靠 …
具有进展快, 预后差, 复发率高等特点, 因此早期干预十分重要. 乳腺癌分子分型的诊断主要依靠 …
[PDF][PDF] Комплексная лучевая диагностика раннего рака молочной железы
ГП Корженкова, ИВ Колядина - Москва, 2021 - ronc.ru
Рак молочной железы (РМЖ)—наиболее распространённая онкологическая патология
у женщин как в России, так и во всём мире. В 2018 году в России было диагностировано …
у женщин как в России, так и во всём мире. В 2018 году в России было диагностировано …
[HTML][HTML] Evolutionary Profil of Triple-Negative Breast Cancer and Influence of Histopronostic Factors: Experience of Oncology Department Chu Ibn Rochd Casablanca
Z Kabala, M Bourhafour, T Chekrine… - European Journal of …, 2023 - ej-med.org
Triple-negative breast cancer (TNBC) is a subgroup of breast cancer with hormone receptor
and Her2 overexpression absence, accounting for 15%–20% of all breast cancers. Its …
and Her2 overexpression absence, accounting for 15%–20% of all breast cancers. Its …